VANESA
ANDRÉS GUERRERO
Profesora contratada doctora
Publicaciones (48) Publicaciones de VANESA ANDRÉS GUERRERO
2024
-
Smart biodegradable hydrogels: Drug-delivery platforms for treatment of chronic ophthalmic diseases affecting the back of the eye
International Journal of Pharmaceutics, Vol. 649
2023
-
A novel osmoprotective liposomal formulation from synthetic phospholipids to reduce in vitro hyperosmolar stress in dry eye treatments
Journal of Liposome Research, Vol. 33, Núm. 2, pp. 117-128
-
Desarrollo de microemulsiones de administración tópicaocular como plataforma para el tratamiento o prevención dela enfermedad de ojo seco
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Desarrollo de una formulación antiglaucomatosa tópica a partir de una lágrima artificial
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Long-acting hybrid microemulsion for the simultaneous treatment of glaucoma and ocular surface diseases
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Microesferas biodegradables de liberación controlada de agentes antioxidantes y anti-inflamatorios como potencial terapia neuroprotectora para el glaucoma
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost
Ocular Surface, Vol. 29, pp. 314-330
2022
-
Cytokine profile in tear and aqueous humor of primary open-angle patients as a prognostic factor for trabeculectomy outcome
European Journal of Ophthalmology, Vol. 32, Núm. 5, pp. 2994-3004
-
Development of an osmoprotective microemulsion as a therapeutic platform for ocular surface protection
International Journal of Pharmaceutics, Vol. 623
-
Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment
Pharmaceutics, Vol. 14, Núm. 7
-
Nuevas terapias hipotensoras en el tratamiento del glaucoma: New hypotensive therapies in the treatment of glaucoma
III Congreso Interdisciplinar de Jóvenes Investigadores 23 y 24 de septiembre de 2021
-
Proinflammatory Cytokine Profile Differences between Primary Open-Angle and Pseudoexfoliative Glaucoma
Ophthalmic research
-
Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release
Pharmaceutics, Vol. 14, Núm. 2
2021
-
Combined hyperosmolarity and inflammatory conditions in stressed human corneal epithelial cells and macrophages to evaluate osmoprotective agents as potential DED treatments
Experimental Eye Research, Vol. 211
-
Dexamethasone PLGA Microspheres for Sub-Tenon Administration: Influence of Sterilization and Tolerance Studies
Pharmaceutics, Vol. 13, Núm. 2, pp. 228
-
Dexamethasone plga microspheres for sub-tenon administration: Influence of sterilization and tolerance studies
Pharmaceutics, Vol. 13, Núm. 2, pp. 1-21
-
Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection
Expert Opinion on Drug Delivery, Vol. 18, Núm. 7, pp. 819-847
-
Microparticle Products for the Eye: Preformulation, Formulation, and Manufacturing Considerations
AAPS Advances in the Pharmaceutical Sciences Series (Springer), pp. 381-407
-
Posterior segment ophthalmic drug delivery: Role of muco-adhesion with a special focus on chitosan
Pharmaceutics, Vol. 13, Núm. 10
-
The effect of a triple combination of bevacizumab, sodium hyaluronate and a collagen matrix implant in a trabeculectomy animal model
Pharmaceutics, Vol. 13, Núm. 6